Novo’s patent in China for semaglutide, the active ingredient used in both Ozempic and Wegovy, is set to expire in 2026
A second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk’s blockbuster diabetes drug Ozempic in China.
Novo’s Ozempic sales in China more than doubled last year to 4.8 billion Danish crowns , accounting for 5 per cent of its total global Ozempic sales, and the company expects approval for its related weight-loss drug Wegovy later this year. The drugmaker is in the midst of a legal fight in the country over the patent and an adverse court ruling could make it lose its semaglutide exclusivity even sooner.
Canada News Breaking News Video Canadian Breaking News Breaking News Globe And Mail Breaking News Globe And Mail Canada News Photos World News Local News National News Us News Foreign News Sports News Arts News Life News Lifestyle Canada Traffic Canada Weather Trudeau Government Federal Government Canada Sports Canada Sports News Politics Politics News Political News Political Opinion Environment Economy Technology Education Travel Canada Alberta Bc British Columbia Manitoba Ontario Quebec Nova Scotia Pei New Brunswick Newfoundland And Labrador Nunavut Northwest Territories Yukon Globe And Mail
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sask. sees astronomical spike in Ozempic claims, many for weight lossUnlike many Ozempic users in Saskatchewan, Chamundi Selvaraj in Saskatoon is taking the diabetes drug for its intended purpose: to regulate her blood sugar levels. She has been dealing with Type 2 diabetes for about a decade.
Read more »
Ozempic claims in Sask. spike more than 3,000% in 5 years, many for weight lossUnlike many Ozempic users in Saskatchewan, Chamundi Selvaraj in Saskatoon is taking the diabetes drug for its intended purpose: to regulate her blood sugar levels. She has been dealing with Type 2 diabetes for about a decade.
Read more »
Ozempic Threat No Match for Krispy Kreme Doughnuts, Truist SaysAmericans love their doughnuts too much to give them up forever, even in spite of the recent boom in weight-loss drugs, says one Wall Street fan of Krispy Kreme Inc.
Read more »
What are ‘Ozempic babies’ and why are women reporting being pregnant while on weight-loss drugs?Ozempic and other medication containing semiglutide continue to be used by people as a weight loss drug and treatment for diabetes, but anecdotal reports on social media appear to show it's having a new result: pregnancy.
Read more »
Denmark Asks Doctors to Move Ozempic Patients to Cheaper DrugsIn Novo Nordisk A/S’s home country of Denmark, authorities now ask doctors to start moving Ozempic patients on to cheaper drugs ahead of stricter subsidies rules coming later this year.
Read more »
Lizzo Reacts To Jokes Made About Her In Ozempic ‘South Park’ SpecialJaz Tolliver is a Trends Reporter for the HuffPost. Previously, she was a Reporter/News Producer for the USA Today Network, where her stories ran across digital and print platforms among newspapers in 43 U.S. states. Jaz has written for the Seattle Times, WPBF 25 News, Boca Magazine, and more.
Read more »